High association between human circulating MicroRNA-497 and acute myocardial infarction

Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Li, Zhenci ^a   Lu, Jing ^a   Luo, Yi ^a   Li, Shaonan ^a   Chen, Minsheng ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 497; TROPONIN I; UNCLASSIFIED DRUG; MIRN497 MICRORNA, HUMAN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; MALE; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UPREGULATION; AGED; BLOOD; CASE CONTROL STUDY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 84904682343     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/931845     Document Type: Article

References (35)

1. White H. D., Chew D. P., Acute myocardial infarction. The Lancet 2008 372 9638 570 584 10.1016/S0140-6736(08)61237-4 2-s2.0-49449104281
2. Anderson J. L., Adams C. D., Antman E. M., Bridges C. R., Califf R. M., Casey D. E. Jr., Chavey 2nd. W. E., Fesmire F. M., Hochman J. S., Levin T. N., Lincoff A. M., Peterson E. D., Theroux P., Wenger N. K., Wright R. S., Smith S. C. Jr., Jacobs A. K., Halperin J. L., Hunt S. A., Krumholz H. M., Kushner F. G., Lytle B. W., Nishimura R., Ornato J. P., Page R. L., Riegel B., ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with. Circulation 2007 116 7 e148 e304 10.1161/CIRCULATIONAHA.107.181940 2-s2.0-34548545280
3. Haaf P., Drexler B., Reichlin T., Twerenbold R., Reiter M., Meissner J., Schaub N., Stelzig C., Freese M., Heinzelmann A., Meune C., Balmelli C., Freidank H., Winkler K., Denhaerynck K., Hochholzer W., Osswald S., Mueller C., High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease. Circulation 2012 126 1 31 40 10.1161/CIRCULATIONAHA.112.100867 2-s2.0-84863609086
4. Alajez N. M., Lenarduzzi M., Ito E., Hui A. B. Y., Shi W., Bruce J., Yue S., Huang S. H., Xu W., Waldron J., O'Sullivan B., Liu F., MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Research 2011 71 6 2381 2391 10.1158/0008-5472.CAN- 10-2754 2-s2.0-79952751773
5. Fukushima Y., Nakanishi M., Nonogi H., Goto Y., Iwai N., Assessment of plasma miRNAs in congestive heart failure. Circulation Journal 2011 75 2 336 340 10.1253/circj.CJ-10-0457 2-s2.0-79251590758
6. Wang G. K., Zhu J. Q., Zhang J. T., Li Q., Li Y., He J., Qin Y. W., Jing Q., Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. European Heart Journal 2010 31 6 659 666 10.1093/eurheartj/ehq013 2-s2.0-77954161288
7. Lewis B. P., Burge C. B., Bartel D. P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005 120 1 15 20 10.1016/j.cell.2004.12.035 2-s2.0-11844278458 (Pubitemid 40094598)
8. Bartel D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009 136 2 215 233 10.1016/j.cell.2009.01.002 2-s2.0-58249088751
9. Filipowicz W., Bhattacharyya S. N., Sonenberg N., Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Reviews Genetics 2008 9 2 102 114 10.1038/nrg2290 2-s2.0-38349169664
10. Cordes K. R., Srivastava D., Ivey K. N., MicroRNAs in cardiac development. Pediatric Cardiology 2010 31 3 349 356 10.1007/s00246-010-9639-3 2-s2.0-77954761402
11. Kim C. W., Vo M., Kim H. K., Lee H. H., Yoon N. A., Lee B. J., Min Y. J., Joo W. D., Cha H. J., Park J. W., Cho W. J., Ectopic over-expression of tristetraprolin in human cancer cells promotes biogenesis of let-7 by down-regulation of Lin28. Nucleic Acids Research 2012 40 9 3856 3869 10.1093/nar/gkr1302 2-s2.0-84861373218
12. Barringhaus K. G., Zamore P. D., MicroRNAs regulating a change of heart. Circulation 2009 119 16 2217 2224 10.1161/CIRCULATIONAHA.107.715839 2-s2.0-66549125217
13. Fichtlscherer S., De Rosa S., Fox H., Schwietz T., Fischer A., Liebetrau C., Weber M., Hamm C. W., Röxe T., Müller-Ardogan M., Bonauer A., Zeiher A. M., Dimmeler S., Circulating microRNAs in patients with coronary artery disease. Circulation Research 2010 107 5 677 684 10.1161/CIRCRESAHA.109. 215566 2-s2.0-77957028990
14. Tijsen A. J., Creemers E. E., Moerland P. D., De Windt L. J., Van Der Wal A. C., Kok W. E., Pinto Y. M., MiR423-5p as a circulating biomarker for heart failure. Circulation Research 2010 106 6 1035 1039 10.1161/CIRCRESAHA.110.218297 2-s2.0-77950973372
15. Chim S. S. C., Shing T. K. F., Hung E. C. W., Leung T., Lau T., Chiu R. W. K., Lo Y. M. D., Detection and characterization of placental microRNAs in maternal plasma. Clinical Chemistry 2008 54 3 482 490 10.1373/clinchem.2007. 097972 2-s2.0-40449127919 (Pubitemid 351348154)
16. Margulies K. B., MicroRNAs as novel myocardial biomarkers. Clinical Chemistry 2009 55 11 1897 1899 10.1373/clinchem.2009.131649 2-s2.0-70449730697
17. Sayed A. S., Xia K., Yang T. L., Peng J., Circulating microRNAs: a potential role in diagnosis and prognosis of acute myocardial infarction. Disease Markers 2013 35 561 566 10.1155/2013/217948
18. Wang S., Li H., Wang J., Wang D., Expression of microRNA-497 and its prognostic significance in human breast cancer. Diagnostic Pathology 2013 8, article 172 10.1186/1746-1596-8-172
19. Luo M., Shen D., Zhou X., Chen X., Wang W., MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor. Surgery 2013 153 6 836 847 10.1016/j.surg.2012.12.004 2-s2.0-84878015086
20. Furuta M., Kozaki K., Tanimoto K., Tanaka S., Arii S., Shimamura T., Niida A., Miyano S., Inazawa J., The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma. PLoS ONE 2013 8 3 e60155 10.1371/journal.pone.0060155 2-s2.0-84875413595
21. Rink C., Khanna S., MicroRNA in ischemic stroke etiology and pathology. Physiological Genomics 2011 43 10 521 528 10.1152/physiolgenomics.00158.2010 2-s2.0-79957649500
22. Yin K. J., Deng Z., Huang H., Hamblin M., Xie C., Zhang J., Chen Y. E., miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiology of Disease 2010 38 1 17 26 10.1016/j.nbd.2009.12.021 2-s2.0-77549088509
23. Zhao S., Zhong Y., Jiang Y. H., Yi Z. W., Circulating microRNA expression in children with idiopathic short stature. Chinese Journal of Contemporary Pediatrics 2013 15 1104 1108
24. Morrow D. A., Cannon C. P., Jesse R. L., Newby L. K., Ravkilde J., Storrow A. B., Wu A. H. B., Christenson R. H., National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 2007 115 13 e356 e375 10.1161/CIRCULATIONAHA.107.182882 2-s2.0-34247271336 (Pubitemid 46648624)
25. Schmittgen T. D., Livak K. J., Analyzing real-time PCR data by the comparative CT method. Nature Protocols 2008 3 6 1101 1108 10.1038/nprot.2008.73 2-s2.0-44949231424 (Pubitemid 351818697)
26. Goren Y., Kushnir M., Zafrir B., Tabak S., Lewis B. S., Amir O., Serum levels of microRNAs in patients with heart failure. European Journal of Heart Failure 2012 14 2 147 154 10.1093/eurjhf/hfr155 2-s2.0-84856208637
27. Turchinovich A., Weiz L., Langheinz A., Burwinkel B., Characterization of extracellular circulating microRNA. Nucleic Acids Research 2011 39 16 7223 7233 10.1093/nar/gkr254 2-s2.0-80052381608
28. Tsui N. B. Y., Ng E. K. O., Lo Y. M. D., Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clinical Chemistry 2002 48 10 1647 1653 2-s2.0-0036794062
29. de Guire V., Robitaille R., Tétreault N., Guérin R., Ménard C., Bambace N., Sapieha P., Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges. Clinical Biochemistry 2013 46 846 860 10.1016/j.clinbiochem. 2013.03.015 2-s2.0-84876969582
30. Fu Y., Yi Z., Wu X., Li J., Xu F., Circulating microRNAs in patients with active pulmonary tuberculosis. Journal of Clinical Microbiology 2011 49 12 4246 4251 10.1128/JCM.05459-11 2-s2.0-82455186873
31. Li L. M., Hu Z. B., Zhou Z. X., Chen X., Liu F. Y., Zhang J. F., Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer Research 2011 70 9798 9807 10.1158/0008-5472.CAN-11-0110 2-s2.0-79952203036
32. Cui L., Qi Y., Li H., Ge Y., Zhao K., Qi X., Guo X., Shi Z., Zhou M., Zhu B., Guo Y., Li J., Stratton C. W., Tang Y., Wang H., Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PLoS ONE 2011 6 11 e27071 10.1371/journal.pone.0027071 2-s2.0-80555129518
33. Ji X., Takahashi R., Hiura Y., Hirokawa G., Fukushima Y., Iwai N., Plasma miR-208 as a biomarker of myocardial injury. Clinical Chemistry 2009 55 11 1944 1949 10.1373/clinchem.2009.125310 2-s2.0-70449709345
34. Oglesby I. K., McElvaney N. G., Greene C. M., MicroRNAs in inflammatory lung disease-master regulators or target practice? Respiratory Research 2010 11, article 148 10.1186/1465-9921-11-148 2-s2.0-77958533034
35. Urbich C., Kuehbacher A., Dimmeler S., Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovascular Research 2008 79 4 581 588 10.1093/cvr/cvn156 2-s2.0-52449100144